Skip to main content
. 2016 Dec 8;43(5):521–545. doi: 10.1080/1040841X.2016.1242868
      Viral glycoprotein processing inhibition
 
Iminosugar and target; concentration INFV strain Cell line Virion production or infectivity inhibition Reference
1-deoxymannojirimycin (DMJ), targeting mannosidase I
 1 mM A/chick/Germany/49 (H10N7) MDCK HA expression unaffected Burke et al. (1984)
    Infectivity (slight). No effect on production  
 2, 10, 25 μg/ml A/NWS/33 (H1N1) MDCK High-mannose oligosaccharide processing and complex chain formation Elbein et al. (1984a)
    No effect on hemagglutination  
 25 μg/ml plus 100 μg/ml CAST A/NWS/33 (H1N1) MDCK No inhibition of oligosaccharide processing (CAST concentration too low to inhibit α-glucosidases)  
    Not tested  
 0.25, 0.5, 1, 2, 4 mM A/Puerto Rico/8/34 (H1N1) MDCK Mannose incorporation (50% at >2 mM)  
    Not tested  
 0.05, 0.1, 0.25, 0.5, 1, 2, 4 mM A/Puerto Rico/8/34 (H1N1) CEC Mannose incorporation  
    Not tested  
 1, 10, 50 μg/ml Unknown MDCK Unaffected Elbein et al. (1990)
    Not tested  
1,4-dideoxy-1,4-imino-d-mannitol (DIM), targeting mannosidase I and II
 10, 100, 250 μg/ml A/NWS/33 (H1N1) MDCK High-mannose oligosaccharide processing Palamarczyk et al. (1985)
    Not tested  
Kifunensine, targeting mannosidase I
 10, 100 ng/ml 1, 10 μg/ml Unknown MDCK High-mannose oligosaccharide processing and complex chain formation Elbein et al. (1990)
    Not tested  
 0.18 mM A/Puerto Rico/8/34/MS (H1N1) MDCK HA sulfation Karaivanova & Spiro (1998)
    Not tested  
 0.18 mM A/Puerto Rico/8/34/MS (H1N1) LLC-PK1 HA sulfation  
    Not tested  
N-benzyl-1,5-dideoxy-1,5-imino-d-mannitol, targeting mannosidases
 10 mM A/fowl plague virus/Rostock/34 (H7N1) MDCK Not tested Huang et al. (1991)
    Haemagglutination and CPE  
N-benzyl-1,5-dideoxy-1,5-imino-4,6-O-isopropylidene-d-mannitol, targeting mannosidases
 10 mM A/fowl plague virus/Rostock/34 (H7N1) MDCK Not tested Huang et al. (1991)
    Haemagglutination and CPE  
3-episiastatin B, targeting NA
 10, 20, 40, 100 μM A/Fort Monmouth/1/47 (H1N1) MDCK IC50 = 74 μM for NA Nishimura et al. (1993)
    PFU 11.1% of control at 40 μM  
 100 μM A/Kayano/57 (H2N2) MDCK IC50 > 10 μM for NA  
    Not tested  
 100 μM B/Lee/40 MDCK IC50 = 42 μM for NA  
    Not tested  
N-nonyl-deoxygalactonojirimycin (NN-DGJ), targeting ceramide-specific glucosyltransferase
 Titration A/Udorn/307/72 (H3N2) MDCK Not tested Hussain et al. (2015)
    HA titer 117 ± 19%, viral titer 97 ± 20%, plaque number 74 ± 16% and plaque size 88 ± 20% of control at 62.5 μM  
 Titration A/Brisbane/10/2007 (H3N2) MDCK Not tested  
    HA titer 75 ± 15%, viral titer 71 ± 21%, plaque number 60 ± 10% and plaque size 76 ± 4% of control at 62.5 μM  
 Titration A/Lviv/N6/2009 (H1N1) MDCK Not tested  
    HA titer 60 ± 10%, viral titer 85 ± 16% and plaque number 73 ± 8% of control at 62.5 μM. No effect on plaque size